GlassScriptPhysician profile
Ashley Rombough
NPI 1669945390
$3,261.42
in general payments reported to CMS, 2019-2025
35 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $404 · 2022: $898 · 2023: $1,102 · 2024: $599 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.81 |
| Education | $153.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $723.64 | 2021-2025 | Lynparza, Tagrisso, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $431.72 | 2021-2025 | Reblozyl, Opdivo, Eliquis |
| Astellas Pharma US INC | $406.92 | 2022-2023 | |
| Amgen INC. | $254.17 | 2021-2023 | Nplate, Vectibix, Xgeva |
| Incyte Corporation | $151.87 | 2021-2024 | Jakafi |
| Seagen INC. | $143.44 | 2021-2023 | Adcetris |
| Novartis Pharmaceuticals Corporation | $138.21 | 2024-2025 | |
| Abbvie INC. | $102.63 | 2024-2025 | |
| Beigene USA, INC. | $102.20 | 2021-2024 | Brukinsa |
| Merck Sharp & Dohme LLC | $101.45 | 2021-2024 | Keytruda, Lynparza, Welireg |
| Karyopharm Therapeutics INC. | $86.15 | 2022-2023 | Xpovio |
| Glaxosmithkline, LLC. | $74.32 | 2023-2025 | Zejula, Jemperli, Ojjaara |
| Eisai INC. | $51.94 | 2022-2023 | |
| Taiho Oncology, INC. | $36.93 | 2024 | |
| Lilly USA, LLC | $34.87 | 2021-2023 | Retevmo, Jaypirca |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmacosmos Therapeutics INC. | $33.24 | 2023-2024 | Monoferric |
| Mirati Therapeutics, INC. | $31.44 | 2023 | Krazati |
| Daiichi Sankyo INC. | $30.77 | 2021-2023 | Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $30.64 | 2021 | |
| Cti Biopharma Corp. | $29.66 | 2023 | Vonjo |
| G1 Therapeutics, INC. | $29.35 | 2023 | Cosela |
| Beone Medicines USA, INC. | $25.84 | 2025 | Brukinsa |
| Adaptive Biotechnologies Corporation | $22.38 | 2025 | Clonoseq |
| Takeda Pharmaceuticals U.S.A., INC. | $18.17 | 2023 | Alunbrig |
| Dendreon Pharmaceuticals LLC | $17.97 | 2025 | Provenge |
| Sumitomo Pharma America, INC. | $17.72 | 2025 | Orgovyx |
| Jazz Pharmaceuticals INC. | $17.46 | 2023 | |
| Emd Serono, INC. | $16.74 | 2024 | |
| Geron Corporation | $15.20 | 2025 | Rytelo |
| Pharmacyclics LLC, An Abbvie Company | $14.83 | 2023 | Imbruvica |
| Sobi, INC | $14.80 | 2024 | |
| Alexion Pharmaceuticals, INC. | $14.51 | 2022 | |
| Janssen Biotech, INC. | $13.81 | 2024 | Darzalex |
| Servier Pharmaceuticals LLC | $13.27 | 2022 | |
| Celgene Corporation | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Rombough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.